Today: 22 March 2026
Browse Category

US Economy 23 January 2026 - 30 January 2026

Eli Lilly stock barely budges after $1.93bn autoimmune pact; Trump touts six U.S. plants

Eli Lilly stock barely budges after $1.93bn autoimmune pact; Trump touts six U.S. plants

Eli Lilly shares closed up 0.03% at $1,024.14 after announcing new research deals in autoimmune disease and gene-editing for hearing loss. Repertoire Immune Medicines will receive $85 million upfront in a collaboration potentially worth $1.84 billion. Lilly also signed a gene-editing agreement with Seamless Therapeutics valued up to $1.12 billion. Investors await Feb. 4 earnings for updates on demand and supply.
Coinbase stock price slides after hours as bitcoin dips below $85,000 and White House stablecoin talks near

Coinbase stock price slides after hours as bitcoin dips below $85,000 and White House stablecoin talks near

Coinbase shares fell 4.8% to $199.18 in after-hours trading Thursday as bitcoin dropped 5.1%. The White House set a Feb. 2 summit with banks and crypto firms on stablecoin rewards, while a Senate panel advanced a digital-asset bill. UK regulators banned a Coinbase ad campaign for downplaying crypto risks.
Heating Oil Price Ticks Up as Iran Risk Lifts Crude; Traders Weigh U.S. Distillate Stocks

Heating Oil Price Ticks Up as Iran Risk Lifts Crude; Traders Weigh U.S. Distillate Stocks

Heating oil futures rose about 0.4% to $2.4566 a gallon Thursday, tracking a surge in crude prices as Middle East tensions escalated. U.S. distillate stocks increased by 329,000 barrels last week, while crude inventories fell by 2.3 million barrels, according to the EIA. Brent crude climbed 2% to near $69.79 a barrel. Traders remain focused on geopolitical risks and upcoming U.S. inventory data.
Roper stock slips again after outlook miss; Deltek in focus as U.S. funding deadline nears

Roper stock slips again after outlook miss; Deltek in focus as U.S. funding deadline nears

Roper Technologies shares fell about 2% Wednesday after its 2026 revenue and profit forecast missed analyst estimates. The company cited weaker demand at its Deltek division, which serves government contractors, and warned that possible U.S. government shutdowns could further impact business. Fourth-quarter revenue reached $2.06 billion, with adjusted EPS at $5.21. Stifel downgraded the stock and cut its price target sharply.
28 January 2026
USA Rare Earth stock slips after $1.6B CHIPS funding letter — what USAR investors are watching next

USA Rare Earth stock slips after $1.6B CHIPS funding letter — what USAR investors are watching next

USA Rare Earth shares fell 6.3% to $24.70 by midday Wednesday after the company announced a $1.6 billion federal package and a $1.5 billion private placement. The Commerce Department offered up to $277 million in direct funding and a $1.3 billion loan, plus equity, for projects in Texas and Oklahoma. Investors raised concerns over dilution and deal terms. The private placement is set to close Jan. 28.
28 January 2026
Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase shares fell 1.2% to $210.83 in after-hours trading Tuesday, despite Cantor Fitzgerald starting coverage with an Overweight rating and a $277 price target. Britain’s ad regulator banned a Coinbase campaign, saying it downplayed crypto risks; Coinbase disputed the ruling. Bitcoin rose 0.7% to $89,313, while Ether gained 2.6%. Coinbase’s next earnings report is pending.
28 January 2026
USA Rare Earth stock whipsaws as $1.6 billion CHIPS-backed plan meets dilution worry

USA Rare Earth stock whipsaws as $1.6 billion CHIPS-backed plan meets dilution worry

USA Rare Earth shares fell 4.9% to $25.42 Tuesday, reversing a Monday rally after news of a $1.6 billion non-binding U.S. government funding letter and a $1.5 billion private share sale. The company’s PIPE is priced at $21.50 and closes Jan. 28. The government package includes a $1.3 billion loan and $277 million in proposed awards. Investors weighed dilution risks and deal terms.
27 January 2026
US gas prices tick higher again as winter storm rattles supply — what drivers watch next

US gas prices tick higher again as winter storm rattles supply — what drivers watch next

U.S. average gasoline prices rose to $2.888 a gallon Tuesday, up 0.7 cent from Monday and 6.6 cents from last week, AAA reported. NYMEX RBOB gasoline futures fell 1.67% to $1.8417 per gallon. Crude prices climbed as a winter storm disrupted U.S. output and Gulf Coast refineries, with Brent at $65.82 and WTI at $60.92. Markets await the EIA’s weekly petroleum report on January 28.
27 January 2026
Today’s US Economic Calendar: Trump Speech, Consumer Confidence and Treasury Auction Set the Tone for Stocks

Today’s US Economic Calendar: Trump Speech, Consumer Confidence and Treasury Auction Set the Tone for Stocks

Health insurers fell sharply premarket after Medicare Advantage rates for 2027 came in below forecasts; UnitedHealth dropped 8%, CVS 9%, and Humana 14%. UPS rose 3.7% after projecting 2026 revenue growth. Nasdaq 100 E-mini futures gained 0.54%, while Dow E-minis slipped 0.08%. The Fed begins its two-day meeting as traders await home-price data and a $70 billion five-year Treasury auction.
27 January 2026
USA Rare Earth stock whipsaws after Trump-backed $1.6 billion plan — what investors watch next

USA Rare Earth stock whipsaws after Trump-backed $1.6 billion plan — what investors watch next

USA Rare Earth shares rose about 8% to $26.72 in after-hours trading Monday after announcing a $277 million federal funding plan and $1.3 billion loan from the Commerce Department’s CHIPS Program. The company also secured $1.5 billion through a private investment in public equity. Trading volume reached 122 million shares. Reuters reported the Trump administration plans to acquire a 10% stake tied to a $1.6 billion deal.
26 January 2026
USA Rare Earth (USAR) stock jumps as U.S. backs $1.6 billion CHIPS-linked funding plan

USA Rare Earth (USAR) stock jumps as U.S. backs $1.6 billion CHIPS-linked funding plan

USA Rare Earth shares surged 17% to $28.94 after announcing a non-binding deal with the U.S. Commerce Department for $277 million in federal funding, a $1.3 billion loan, and a $1.5 billion PIPE. The funding would support a Texas rare earth mine and an Oklahoma magnet plant. A $1.5 billion private placement is set to close January 28. The deal faces hurdles before final agreements are reached.
26 January 2026
Critical Metals stock flips lower after early surge as U.S. rare-earth deal jolts sector

Critical Metals stock flips lower after early surge as U.S. rare-earth deal jolts sector

Critical Metals Corp shares fell 9.5% to $18.66 by mid-morning after a volatile start, despite rare-earth stocks initially rising on news of U.S. support for USA Rare Earth’s $1.6 billion financing package. Traders are seeking details on Critical Metals’ Greenland project timeline and funding. USA Rare Earth jumped 15% after announcing federal backing and a $1.5 billion PIPE deal.
26 January 2026
NioCorp stock jumps premarket as Trump administration rare-earth deal lifts U.S. critical minerals names

NioCorp stock jumps premarket as Trump administration rare-earth deal lifts U.S. critical minerals names

NioCorp shares rose 5.6% to $7.70 in early Monday trading after news of a $1.6 billion federal funding package for USA Rare Earth lifted the sector. The U.S. Department of Defense recently awarded NioCorp up to $10 million for its Elk Creek project. The company reported $307 million in cash at year-end and plans to file its quarterly report by Feb. 16. Investors remain alert to dilution risk after a new equity agreement filing.
USA Rare Earth (USAR) stock jumps in premarket on report of $1.6 billion U.S. investment

USA Rare Earth (USAR) stock jumps in premarket on report of $1.6 billion U.S. investment

USA Rare Earth shares jumped 38% to $34.20 in premarket trading after reports the Trump administration will take a 10% stake in the company as part of a $1.6 billion debt-and-equity deal. The funding, tied to the CHIPS Act, aims to support a U.S. rare earths mine and magnet plant. An official announcement is expected Monday. Investors await details on financing terms and possible share dilution.
26 January 2026
MP Materials stock: what traders are watching after a fresh U.S. rare-earths funding signal

MP Materials stock: what traders are watching after a fresh U.S. rare-earths funding signal

MP Materials shares rose 1.8% to $69.58 Friday ahead of a $1.6 billion U.S. investment package for rare earths expected Monday. The Trump administration plans to acquire a 10% stake in USA Rare Earth, according to sources cited by Reuters. Investors are watching for policy impacts and MP’s next earnings update, set for Feb. 19. The Financial Times reports the deal includes equity, warrants, and loans for mine and magnet factory construction.
25 January 2026
USA Rare Earth stock faces Monday test after report of $1.6 billion U.S. stake deal

USA Rare Earth stock faces Monday test after report of $1.6 billion U.S. stake deal

USA Rare Earth (USAR.O) shares jumped 9.1% to $24.77 Friday after sources said the U.S. will take a 10% stake in a $1.6 billion deal, with an announcement expected Monday. The government is set to receive 16.1 million shares and warrants for 17.6 million more at $17.17 each. Investors await details on financing terms and possible dilution. The White House and company declined comment.
US economic calendar today: Intel slides, Wall Street futures dip ahead of PMI and Michigan sentiment

US economic calendar today: Intel slides, Wall Street futures dip ahead of PMI and Michigan sentiment

U.S. stock futures slipped early Friday after Intel shares plunged 13.6% on a weak outlook. At 5:57 a.m. ET, S&P 500 E-minis were down 0.23%, Nasdaq 100 E-minis fell 0.35%, and Dow E-minis dropped 0.24%. Investors await key PMI data and the Michigan sentiment index later this morning. Intuitive Surgical rose 3.7% premarket after beating earnings estimates.
23 January 2026
1 2 3 4 5 12

Stock Market Today

  • CRISPR Therapeutics Stock Dips Amid Biotech Risks Despite Strong DCF Upside
    March 22, 2026, 2:39 AM EDT. CRISPR Therapeutics (CRSP) shares have fallen 14% year to date, contrasting with a 12.2% gain over the past year. The stock trades around $46.24, reflecting a 75.6% discount to its intrinsic value based on a Discounted Cash Flow (DCF) model projecting positive free cash flow by 2030. Despite short-term declines driven by biotech sector volatility and regulatory concerns, long-term growth potential linked to its gene-editing pipeline keeps investor interest. The company shows a $345.4 million free cash flow loss currently, moving to forecasted positive cash generation. Valuation metrics like price-to-book provide additional context amid earnings volatility. Market watchers may consider CRISPR's current weakness an opportunity, though risks remain given sector dynamics and cash flow uncertainty.
Go toTop